ࡱ> TXS ?bjbj 40xx 1  KKKKK___84L_<>(???...<<<<<<<$>vA*;<K.....;<KK??P<.FK?K?<.<657?h"u;_t^5<f<0< 6B*B877\BK7.......;<;<...<....B......... : Possible Side Effects of Oxaliplatin (Table Version Date: November 9, 2016) COMMON, SOME MAY BE SERIOUS In 100 people receiving Oxaliplatin, more than 20 and up to 100 may have:Anemia which may require blood transfusion Diarrhea, nausea, vomiting, constipation, loss of appetite Tiredness Bruising, bleeding Infection, especially when white blood cell count is low Numbness, tingling or pain, "pins and needles" of the hands, feet, arms and legs Tingling or a loss of feeling in your hands, feet, nose, or tightness in throat or jaw, or difficulty swallowing or breathing which may be made worse by exposure to cold Pain Fever, cough OCCASIONAL, SOME MAY BE SERIOUS In 100 people receiving Oxaliplatin, from 4 to 20 may have:Blood clot which may cause swelling, pain, or shortness of breath Abnormal heartbeat which may cause fainting Hearing loss Problem with eyelid Difficulty walking, using your hands, opening mouth, talking, with balance and hearing, smelling, eating, sleeping, emptying the bladder Swelling of the body which may cause shortness of breath Blockage of the airway which may cause shortness of breath, cough, wheezing Bleeding from multiple sites including vaginal bleeding, bleeding of the testis, or bleeding of the brain Internal bleeding which may cause black tarry stool, blood in vomit or urine, or coughing up blood Sores in throat or mouth which may cause difficulty swallowing Swelling and redness at the site of the medication injection Liver damage which may cause yellowing of eyes and skin Kidney damage which may require dialysis Allergic reaction which may cause rash, low blood pressure, wheezing, shortness of breath, swelling of the face or throat Weight gain, weight loss, dehydration Dizziness, headache Changes in taste, voice Abnormal body movement including the eye and eyelid Inability to move shoulder or turn head Muscle weakness Scarring of the lungs Hair loss, itching, rash, hives RARE, AND SERIOUS In 100 people receiving Oxaliplatin, 3 or fewer may have:Redness, pain or peeling of palms and soles     Page  PAGE 1 of  NUMPAGES 1 4:JLgh  $ 6 o w x ³£vgvgXvI=Ih]!CJOJQJaJh.h]!CJOJQJaJh.hjCJOJQJaJh.h<1CJOJQJaJh.h7KCCJOJQJaJh.h9CJOJQJaJh.hQCJOJQJaJh.h?¾¾¾¾wwlhh hCwh CJaJ$hh5CJOJQJaJmHnHuhCwh 5CJOJQJaJ(jhCwh 5CJOJQJUaJhCwh CJOJQJaJh?rjh?rUh.hjaJh.hQCJOJQJaJh Cbh7KCCJOJQJaJhh^CJOJQJaJ   <=>~~~~v~~$a$gdCwgdd[$\$gdmHjkd$$IflT*) t0644 la ytQ6 >?d[$\$gdmH21:pQ/ =!"#$%` $$If !vh5)#v):V l44 t065)a f4p ytPn$$If !vh5)#v):V l t065)a ytQ6$$If !vh5)#v):V l44 t065)a f4p ytPn$$If !vh5)#v):V l t065)a ytQ6$$If !vh5)#v):V l44 t065)a f4p ytPn$$If !vh5)#v):V l t065)a ytQ6j  666666666vvvvvvvvv66666>666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH J`J VNormal$a$OJPJQJ_HmH sH tH N`N C Heading 1@&CJOJQJaJmHsHtHDA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List :) : V Page Number CJOJQJ@ @ VHeader ! mHsHtHF/F V Header CharCJOJPJQJ^JaJ@ `"@ V0Footer ! mHsHtHF/1F V0 Footer CharCJOJPJQJ^JaJR^@BR V Normal (Web)dd[$\$a$ CJOJQJfRf V Colorful List - Accent 1 ^a$m$CJOJQJaJtct Q Table Grid7:V0 dP rP Q0 Balloon TextCJOJQJaJmHsHtHR/R Q0Balloon Text CharCJOJPJQJ^JaJB' B 10Comment ReferenceCJaJ@ @ 10 Comment Text mHsHtHR/R 10Comment Text CharCJOJPJQJ^JaJ@j @ 10Comment Subject5\^/^ 10Comment Subject Char5CJOJPJQJ\^JaJH/H C Heading 1 CharCJOJPJQJaJ8W`8 .`Strong5CJOJQJaJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] ? 0 0003 , ? 6 j  >? +-3!L# @0(  B S  ? =@K (,=@44:JojVVjj~EE""ZZoq     (,;@ Bidt~u 8[rx6K€ 1%QM+QDRkXpR.Xjt=6QyxxT ^`OJQJo( 8^8`OJQJo(^`OJQJ^Jo(o  p^ `OJQJo(  @ ^ `OJQJo( x^x`OJQJo(H^H`OJQJ^Jo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( |^`|OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( ^`OJQJo(^`OJQJ^Jo(o p^p`OJQJo( @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o P^P`OJQJo( 1%Qtu rdRR.X+QQy6K                                                                         g                 QW1dM$>`L*Z3EW0O9ePC fM {  <w)bJ-Je^S>{7y"{7p1 <!g:0I; =h={>)?e?k@p@B[0C`2C7KC1EFHUHmHFI?GKa?LiNO]QiQHRPR]RSS;`S&UXlfYyYPZf^{i^&3`ea CbTb;Zc= dacde ee f5fvf@[ghii#lw.mUn"dno"iz#|G xdXy,9zl!KE~jg)4xZd[ wG{/ /lV9f%?HNz-;`s ,41P <1h9 KUPn5zjr-':jDnZ 9 eJ 'w`\ -Ef @IIHIIT*?`@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.@Calibri[BookmanBookman Old Style5. .[`)Tahoma?= *Cx Courier New;WingdingsA$BCambria Math" hSK SK4G]*+]*+!r0 3qHX  $PV2!xx$Possible Side Effects of Oxaliplatin$Possible Side Effects of Oxaliplatin"Possible Side Effects, Oxaliplatin HHS/DCTD/CTEP Jean Zhao8         Oh+'0<P dp    (Possible Side Effects of Oxaliplatin(Possible Side Effects of OxaliplatinHHS/DCTD/CTEP$Possible Side Effects, Oxaliplatin Normal.dotm Jean Zhao14Microsoft Office Word@V@Q+H|@t;@!u;]՜.+,D՜.+,l( px   Document+* %Possible Side Effects of Oxaliplatin TitleP 5= LanguageEnglish  "#$%&'()*+,-./0123456789:;<=>?@ABDEFGHIJLMNOPQRUVWeZ[\]^_`abcdRoot Entry Fp7k"u;YData 1Table!BWordDocument40SummaryInformation(CDocumentSummaryInformation8KMsoDataStore]"u;h"u;CFEWXIQQRY3==2 ]"u;h"u;Item  Properties7m5IUROO50FGB==2 ]"u;h"u;Item  EPropertiesIO12LPWGPEBA==2]"u;h"u;Item O PropertiesTU  !"#$%&'()*+,-./012345689:;<=>?@ABCDFGHJKLMNPQRSUVWXY[ This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. DocumentLibraryFormDocumentLibraryFormDocumentLibraryForm   F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89qCompObjZy